Insider trading

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,041 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,041 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,041 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,041 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,041 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,041 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,041 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
Duncan David R Director · indirect
Sold at will 3×
$220.51K 8,626 at 25.56
100%
Sold half or more
3 Feb 2026
WALTERS KIRK W Director
Sold at will
$206.68K 909 at 227.37
13.2%
Not planned
3 Feb 2026
Orenstein Gregory CFO & Treasurer
Sold at will
$197.32K 10,562 at 18.68
2.3%
Not planned
3 Feb 2026
Sathyanarayanan Bala EVP, Chief Human Resources Off
Sold at will
$180.65K 2,499 at 72.29
5.0%
Not planned
3 Feb 2026
Remer Eric Richard Chief Executive Officer
Sold on a plan 2×
$178.87K 16,403 at 10.90
0.6%
Planned (10b5-1)
3 Feb 2026
Singh Ritadhwaja Jebens EVP & CHIEF DIGITAL OFFICER
Sold on a plan
$178.22K 5,880 at 30.31
5.4%
Planned (10b5-1)
3 Feb 2026
Yu Gary President and CEO
Sold at will
$176.47K 2,900 at 60.85
2.5%
Not planned
3 Feb 2026
Richards Jay D. Officer of Subsidiary
Sold at will
$174.70K 3,506 at 49.83
8.9%
Not planned
3 Feb 2026
Takao Justin Treasurer, CAO & CFO
Sold at will 3×
$173.47K 14,807 at 11.72
69.6%
Sold half or more
3 Feb 2026
Sold at will
$156.31K 11,000 at 14.21
64.0%
Sold half or more
3 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
3 Feb 2026
Rieger April Chief Lgl. & Admin Ofc., Sec
Sold at will
$150.91K 8,078 at 18.68
3.5%
Not planned
3 Feb 2026
Claussen James J Executive Vice President & CFO
Sold on a plan
$149.16K 4,972 at 30.00
6.3%
Planned (10b5-1)
3 Feb 2026
FISHER ERIKA ASHLEY Chief Legal Officer
Sold on a plan
$148.36K 589 at 251.88
5.1%
Planned (10b5-1)
3 Feb 2026
Smith Jason Drew General Counsel
Sold at will 3×
$147.26K 7,479 at 19.69
12.7%
Not planned
3 Feb 2026
Schoenberg Mark Chief Medical Officer
Sold at will 3×
$145.17K 7,373 at 19.69
4.8%
Not planned
3 Feb 2026
INGLIS ANDREW G Chairman and CEO
Sold on a plan
$141.87K 103,554 at 1.37
2.4%
Planned (10b5-1)
3 Feb 2026
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$139.18K 4,333 at 32.12
8.1%
Not planned
3 Feb 2026
Okupe Oluyemi Chief Financial Officer
Sold on a plan
$139.11K 5,262 at 26.44
5.4%
Planned (10b5-1)
3 Feb 2026
STICKELS ERIC Director
Sold at will
$129.49K 2,000 at 64.75
5.7%
Not planned
3 Feb 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan
$127.72K 3,200 at 39.91
3.6%
Planned (10b5-1)
3 Feb 2026
Beckman Daniella Chief Financial Officer
Sold at will 2×
$126.53K 10,317 at 12.26
5.3%
Not planned
3 Feb 2026
Finn Patrick John President and COO
Sold at will
$125.99K 2,705 at 46.58
0.9%
Not planned
3 Feb 2026
Indelicarto Thomas C EVP, Gen Counsel & Secretary
Sold on a plan 2×
$124.04K 498 at 249.08
1.6%
Planned (10b5-1)
3 Feb 2026
Flammer Martina M.D. Chief Medical Officer
Sold on a plan
$123.84K 795 at 155.77
0.9%
Planned (10b5-1)
3 Feb 2026
Adsett Roger Chief Operating Officer
Sold at will
$123.53K 791 at 156.17
0.7%
Not planned
3 Feb 2026
GOEBEL MARYANN Director
Sold at will
$117.03K 3,419 at 34.23
36.3%
Not planned
3 Feb 2026
Sold at will
$116.96K 3,419 at 34.21
77.4%
Sold half or more
3 Feb 2026
Bonstein Sara Chief Financial Officer
Sold at will
$116.94K 748 at 156.34
0.9%
Not planned
3 Feb 2026
Longitude Capital Partners II, LLC 10% owner · indirect
Sold at will
$116.64K 27,500 at 4.24
35.9%
Not planned
3 Feb 2026
Roller David L. Senior Vice President
Sold at will
$111.55K 2,092 at 53.32
6.7%
Not planned
3 Feb 2026
Foehr David Senior VP, Finance and PAO
Sold on a plan 2×
$111.12K 5,556 at 20.00
22.7%
Planned (10b5-1)
3 Feb 2026
Sold on a plan 2×
$109.90K 10,000 at 10.99
0.5%
Planned (10b5-1)
3 Feb 2026
Sumner R Nichole VP & Controller
Sold at will
$106.85K 4,750 at 22.49
16.1%
Not planned
3 Feb 2026
Sheena Jonathan Director
Sold on a plan
$100.38K 435 at 230.77
0.2%
Planned (10b5-1)
3 Feb 2026
Smith Michael Alexander Chief Legal Officer
Sold at will
$100.01K 640 at 156.27
1.1%
Not planned
3 Feb 2026
Gupta Sunil VP of Operations
Sold at will 2×
$98.83K 2,168 at 45.58
2.2%
Not planned
3 Feb 2026
Sold on a plan
$96.50K 10,500 at 9.19
14.4%
Planned (10b5-1)
3 Feb 2026
Schulz Tamara L Chief Accounting Officer
Sold on a plan
$91.31K 1,527 at 59.80
1.5%
Planned (10b5-1)
3 Feb 2026
Novack Jeffrey Adam Secretary and General Counsel
Sold at will
$91.29K 4,441 at 20.56
3.4%
Not planned
3 Feb 2026
Smith Chad M. Pres & COO, Better Mortgage · indirect
Sold on a plan
$83.80K 3,097 at 27.06
14.3%
Planned (10b5-1)
3 Feb 2026
Yi Steven See Remarks
Sold on a plan
$80.33K 8,000 at 10.04
0.3%
Planned (10b5-1)
3 Feb 2026
Sold at will
$76.44K 2,279 at 33.54
24.6%
Not planned
3 Feb 2026
Shah Nealesh D. SVP and CFO
Sold on a plan
$74.57K 54,434 at 1.37
3.1%
Planned (10b5-1)
3 Feb 2026
O BRIEN DANIEL B Chief Executive Officer
Sold at will
$73.50K 12,500 at 5.88
0.3%
Not planned
3 Feb 2026
Nonko Eugene Director · indirect
Sold on a plan
$67.42K 6,700 at 10.06
0.5%
Planned (10b5-1)
3 Feb 2026
WILLIAMS JOHN B Director
Sold at will
$65.20K 2,325 at 28.05
3.2%
Not planned
3 Feb 2026
Turner Matthew Baker PRES., PATIENT AFFORDABILITY
Sold at will
$62.64K 15,057 at 4.16
3.2%
Not planned
3 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$62.31K 4,170 at 14.94
2.6%
Planned (10b5-1)
3 Feb 2026
WESTBROOKS KRISTOPHER R President & COO
Sold on a plan
$62.06K 2,951 at 21.03
1.5%
Planned (10b5-1)
Showing 33,951–34,000 of 46,041. ← Newer Page 680 of 921 Older →